Download presentation
Presentation is loading. Please wait.
Published byBeverley Goodman Modified over 9 years ago
1
B Cell Tolerance Wendy Davidson Ph.D. May 3, 2011 Contact information: Email:davidsonw@niaid.nih.gov Tel:301-402-8399
2
What is B cell tolerance? The adaptive immune system has evolved to generate Ab against any foreign protein. This unlimited repertoire will include autoreactive specificities with the potential to cause disease. 50-75% of B cells produced in BM are autoreactive. B cell tolerance is the process by which autoreactive B cells are silenced. Self tolerance is achieved by a series of checkpoints that target autoreactive B cells at different stages of development. Central (BM) and peripheral tolerance. B cells responsive to foreign Ag can be rendered tolerant by varying the dose of Ag. High vs low zone tolerance. IgE-mediated allergy.
3
Ig transgenic mice are useful models for studying mechanisms of B cell selection Most common model: Anti-hen egg lyzozyme (HEL) transgenic mice crossed with mice where HEL is expressed as an endogenous soluble self antigen (sHEL) or a membrane bound self antigen (mHEL). Other models: Anti-ssDNA, -dsDNA, -rheumatoid factor, Ars/A1, - Smith, -RBC and -insulin. Models used to demonstrate mechanisms of B cell repertoire selection in the BM and periphery (deletion, receptor editing and anergy).
4
Single Cell B Cell cloning Uses BCR repertoire analysis- general and subset specific B cell development B cell selection B cell response to infection or vaccines (clonality, affinity, protection, vaccine design) Identification of Abs with specific properties (e.g. Flu vaccines) BCR repertoire analysis in disease (e.g. SLE before and after treatment)
5
Comparison of anergic B cell phenotypes in BCR transgenic mice Cambier JC 2007
6
Stages of B cell development and repertoire editing Cambier JC Nature, 2007 Checkpoint 1 Newly formed B cells Checkpoint 2 Transitional B cells Checkpoint 3 GC Central tolerance Peripheral tolerance Ag independent
7
Sequence of B cell selection and maturation
8
CHECKPOINT 1 (Central tolerance): Possible fates of newly formed immature autoreactive B cells in BM Self antigens expressed in BM: Receptor editing Deletion Anergy Self antigens not expressed in BM: Escape (Ignorance)
9
Possible Fates of Immature B Cells in the BM e.g. mHELe.g. sHEL Death by Bim- dependent pathway e.g. anti-IgG (RF)
10
CHECKPOINT 1: Receptor editing Major mechanism for eliminating autoreactive specificities from the developing B cell repertoire 4-8x10 7 immature B cells generated/day and a high proportion (~75%) of these are autoreactive. By single cell PCR analyses, ~2/3 of immature B cells in BM have secondary rearrangements of IgL genes, exhibit Ig gene rearrangements and continue to express RAG 1 and 2. Many of these cells do not make it out of the BM, since only ~1/2 of immature and mature B cells in the periphery show evidence of receptor editing. Receptor editing occurs predominantly in the BM. (F. Melchers 2006. Immunity:25:864)
11
CHECKPOINT 1: Ig Receptor Editing in BM Developmental arrest associated with inhibition of expression of homing receptors and BAFF-R and persistent expression of RAG-1,-2. Bim-dependent apoptosis
12
Anergy in immature BM cells Anergy is a potentially reversible state of tolerance (unresponsiveness) that develops when immature autoreactive BM B cells bind abundant low avidity or soluble Ag that does not produce a sufficiently strong signal to induce receptor editing or deletion. Anergy is associated with developmental arrest, increased threshold for activation by Ag, altered migration and shortened lifespan in the periphery. Anergy is plastic and mechanistically diverse. Spectrum of anergic phenotypes - influenced by Ag reactivity.
13
Properties of anergic peripheral B cells in Ig transgenic mice Migrate to the spleen and reside in the extra-follicular T cell zones or red pulp and are generally excluded from the follicles. Retain Ag-binding capacity but are Ag unresponsive. Have high basal intracellular Ca++ levels, positive signaling via the BCR is blocked. Short half life (2-3 days) and an increased dependence on BAFF for survival compared to functional B cells. Can be rescued if BAFF is present in excess and competing non-Tg B cells are absent or reduced in number. Maintenance of anergy is dependent on continuous binding of Ag and inhibitory BCR signaling. Anergy can occur in immature and mature B cells and is reversible. Escape from anergy can result in autoimmunity.
14
Anergic B cells have diverse phenotypes in BCR Tg mice Cambier JC, Nature Reviews, 2007
15
Factors that contribute to the increased threshold of activation in anergic B cells HEL and Ars/A1 models: 1.Continuous signaling via self Ag/BCR 2.Decreasd surface IgM 3.Chronic ERK and NFAT signaling 4.Increased intracellular Ca ++ 5.Constitutive activation of SHIP-1 and DOK-1 6. Inhibition of activation of Syk and Akt survival pathway Ferry et.al. 2006. Transplantation 81:308-315
16
B cell signaling in response to acute and chronic stimulation Cambier JC, Nature Reviews, 2007 Dual phosphorylation of ITAMS Mono phosphorylation of ITAMS SHIP1 and DOK activated by LYN, modulate signaling Chronic BCR signaling required to maintain anergic state Anergy reversible by removal of Ag Most relevant to MD4XMD5 and Ars/A1 Tg models
17
Anergic B cells can be rescued from death if sufficient BAFF is available Fas/FasL and CD40/CD40L interactions also may contribute to the death of anergic B cells Ferry et.al. 2006. Transplantation 81:308-315
18
Other mechanisms for rescuing autoreactive anergic B cells signaling threshold, negative signaling CD22-/-, SHIP1-/-, FcR IIb-/- mice exposure to auto Ag Transfer autoreactive Tg B cells to auto Ag-free environment Cross anti-DNA and anti-Sm Tg mice to autoimmune MRL-lpr or B6-lpr mice Reduce the affinity of the BCR Defects in cell death pathways (Fas, Bim)
19
Stages of B cell development and repertoire editing: Checkpoint 2 Cambier JC Nature, 2007 Checkpoint 1 Newly formed B cells Checkpoint 2 Transitional B cells Checkpoint 3 GC Central tolerance Peripheral tolerance
20
Stages of transitional B cells BMSpleen Immature B cells sIgM + IgD- CD93+ CD23- CD21- CD24 ++++ Rag1, Rag2 +/- Transitional B cells T1 T2 T3 follicular B cells sIgM ++ ++ + +/++ IgD - ++ ++ ++ CD93 ++ + + - CD23 - + + + CD21 - + + + CD24 ++++ +++ ++ + Rag1,2 - - - - Non-dividing, half-life 2-4 days CD93 = AA4.1 CD24= HSA
21
Proposed Model of Human B-Cell Development
22
Differentiation of transitional B cells in the spleen Immature B cells T1T2 Naïve B cell Autoantigens Anergic B cell T3 Ag removal and decreased stimulation threshold Autoreactive naïve B cell Induction of anergy Increasing BAFF-R expression J. Cambier, Immunity 2006; M. Cancro, Immunol. Rev. 2004 Significant cell loss Only ~5% of immature B cells produced in BM enter the mature B cell pool. Mature B cell Dependence on BAFF for survival BMSP Rescue Death
23
Properties of BAFF BAFF (BLyS, TALL-1, THANK, zTNF4) and APRIL, a related cytokine, are members of the TNF super family. BAFF interacts with three receptors BAFF-R (BR3), BCMA and TACI expressed predominantly on B lineage cells. APRIL binds to BCMA and TACI only. BAFF is produced predominantly by myeloid cells and acts on transitional, naive and mature B cells. BAFF is essential for normal B cell development and survival in the periphery. BAFF-deficient mice are deficient in B2 cells and MZ B cells but have normal numbers of B1 cells. BAFF Tg mice have excess mature B cells, especially MZ B cells, and develop systemic autoimmunity and B cell lymphomas with age.
24
BAFF governs successful transitional B cell differentiation by enhancing survival Interactions between BAFF and BAFF-R are essential for maturation of transitional B cells. BAFF-R-deficient mice have severely impeded transitional B cell differentiation and mature B cells with significantly shortened lifespans. TACI and BCMA KO mice exhibit normal transitional B cell differentiation. BAFF-R expression increases as T1 cells differentiate into T2 cells. Competition for available BAFF dictates the lifespan of anergic B cells and resting transitional, naïve and mature B cells.
25
Mechanisms of BAFF-induced survival of B cells BAFF supports the survival of transitional and mature B cells without inducing proliferation. BAFF contributes to B cell survival by inducing the expression of pro- survival members of the Bcl-2 family and interfering with the nuclear translocation of pro-apoptotic PKC to the nucleus. BCR ligation upregulates expression of BAFF-R, but not TACI or BCMA, on late transitional and mature B cells. Both BCR- and BAFF-R mediated signals appear to be essential for repertoire selection and survival of mature B cells.
26
Models 1 and 2: Excess BAFF does not rescue cells deleted early in development. Models 3 and 4: Responsiveness to excess BAFF corresponds to a maturational change in T2 cells involving expression of BAFF-R. Influence of excess BAFF on the selection of self- reactive B cells Thien et. al. 2004. Immunity 20:785-798.
27
Anergic B Cells are Susceptible to Fas-mediated Death
28
Differentiation of transitional B cells in the spleen Immature B cells T1T2 Naïve B cell Autoantigens Anergic B cell T3 Ag removal and decreased stimulation threshold Autoreactive naïve B cell Induction of anergy Increasing BAFF-R expression J. Cambier, Immunity 2006; M. Cancro, Immunol. Rev. 2004 Significant cell loss Only ~5% of immature B cells produced in BM enter the mature B cell pool. Mature B cell Dependence on BAFF for survival BMSP Rescue Death
29
Evidence that anergic B cells and T3 cells have similar properties Both have a similar surface phenotype (CD93 + CD23 + IgM lo, CD24 inter, IgD hi ) and lifespan. Non-autoreactive BCR transgenic mice have few T3 cells suggesting that this population may not represent a developmental stage between T2 and naïve B cells. Maintenance of the T3 phenotype requires continuous antigen exposure T1 and T2 B cells are only found in the blood and spleen. Anergic B cells with the phenotype of T3 cells are detectable in spleen, LN and blood. Anergic B cells and T3 cells have similar abnormalities in BCR signaling and have constitutively activated ERK and DOK-1. T3 cells from normal mice are enriched for autoreactive specificities and have a similar gene expression profile to HEL Tg anergic B cells.
30
Potential dangers of having large numbers of anergized B cells produced during B cell selection. The T3/anergic B cell population in normal mice ranges from 1-5x10 6 cells/spleen and ~50% of these are replaced every 4 days (Merrell et.al. 2006.Immunity 25:953-962). Previous estimates suggest that ~5x10 6 new B cells arrive in the spleen every 4 days (Rolink et.al. 1998. EJI 28:3738-3748). Therefore, a significant proportion (upto ~50%) of the B cells entering the spleen every four days from BM may be anergic or become anergic (Merrell et.al. 2006.Immunity 25:953-962). Since anergy is potentially reversible, having large numbers of anergic autoreactive B cells in the periphery poses a significant risk of autoimmunity. However, under normal circumstances, this danger is likely kept in check by the short half life of anergic B cells. (Merrell et.al. 2006.Immunity 25:953-962).
31
Possible mechanisms for rescue and activation of autoreactive anergic B cells 1. Increased availability of BAFF 2. Removal of self Ag 3. High avidity Ag stimulation + T cell help 4. TLR signals 5. Defects in Fas, Bim signaling 6.Altered signaling threshold Ferry et.al. 2006. Transplantation 81:308-315 RESCUE AUTOIMMUNITY
32
Autoreactive B cells generated in germinal centers by somatic hypermutation normally are eliminated. Possible role for Fas/FasL. Lack of T cell help CHECKPOINT 3: Elimination of autoreactive B cells generated in GC
33
Defects in the induction and control of B cell tolerance lead to systemic autoimmunity Topics for lecture 2: Sources of autoreactive B cells (incompletely tolerized cells, ignorant B cells) Sites and mechanisms of activation of autoreactive B cells (antigens, TLRs, extrafollicular responses) Contributions of autoreactive B cells to disease (effectors and APC)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.